The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers

Drug and Alcohol Dependence

Volumn 68, Issue 1, 2002, Pages 23-33

  Wachtel, Stephen R ^a,b   Ortengren, Amanda ^a   De Wit, Harriet ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b EVANSTON NORTHWESTERN HEALTHCARE   (United States)

Author keywords

Amphetamines; Dopamine; Serotonin; Stimulant; Subjective effects

Indexed keywords

DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; METHAMPHETAMINE; PLACEBO; RISPERIDONE; SEROTONIN ANTAGONIST; CENTRAL STIMULANT AGENT; DOPAMINE; SEROTONIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHYSIOLOGY; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEDATION; STANDARDIZATION; ADOLESCENT; AFFECT; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; EMOTION; METABOLISM; URINE;

ADOLESCENT; ADULT; AFFECT; CENTRAL NERVOUS SYSTEM STIMULANTS; COMPARATIVE STUDY; DOPAMINE; DOPAMINE ANTAGONISTS; DOUBLE-BLIND METHOD; EMOTIONS; FEMALE; HALOPERIDOL; HUMAN; MALE; METHAMPHETAMINE; RISPERIDONE; SEROTONIN; SEROTONIN ANTAGONISTS; SUPPORT, U.S. GOV'T, P.H.S.; HUMANS;

ANIMALIA;

EID: 0036708074     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(02)00104-7     Document Type: Article

References (71)

1. The antagonism of amphetamine induced symptomatology by a neuroleptic
2. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence
3. Role of dopamine in d-amphetamine-induced euphoria in normal, healthy volunteers
4. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal healthy volunteers
5. High dose pimozide does not block amphetamine-induced euphoria in humans
6. 2 receptor function in rats
7. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations in the nucleus accumbens of freely moving rats
8. Reinforcing and subjective effects of several anorectics in normal human volunteers
9. Reinforcing and subjective effects of oral A9-THC and smoked marijuana in humans
10. Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans
11. Single-dose bromocriptine reverses cocaine craving
12. Brief comparison of the pharmacokinetics and pharmacodynamics of the traditional and newer antipsychotic drugs
13. The reinforcing properties of amphetamine in overweight subjects and depressed subjects
14. SCL-90-R manual II
15. 2 receptor-mediated behavior and on extracellular concentrations of serotonin and dopamine
16. Assessment of abuse liability of stimulant drugs in humans: A methodological survey
17. Reliability, validity, and clinical application of the Visual Analogue Mood Scale
18. Outpatient treatment of 'crack' cocaine smoking with flupenthixol decanoate. A preliminary report
19. Bromocriptine-desipramine protocol in the treatment of cocaine addiction
20. 3 receptor antagonist ondansetron, in healthy volunteers
21. Similarities in animal and human drug-taking behavior
22. Clinical trials with amphetamine-blocking drugs
23. Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans
24. Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys
25. Negatively reinforcing properties of some psychotropic drugs in drug-naive rhesus monkeys
26. Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects
27. Drug preference and mood in humans: D-amphetamine
28. The pharmacology of cocaine related to its abuse
29. Effects of alpha-methyltyrosine in amphetamine-dependent subjects
30. Pharmacological blockade of amphetamine effects in amphetamine-dependent subjects
31. Drug discrimination by humans compared to nonhumans: Current status and future directions
32. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain
33. Cellular and molecular mechanisms of drug dependence
34. Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis
35. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: Comparison with amphetamine
36. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine
37. Effects of amphetamine, methylphenidate, and apomorphine on regional brain serotonin and 5-hydroxyindole acetic acid
38. Human d-amphetamine drug discrimination: Methamphetamine and hydromorphone
39. In vitro and in vivo receptor binding and effects on monamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone
40. Neuroleptics block the positive reinforcing effects of amphetamine but not morphine as measured by place conditioning
41. Failure of Δ9-tetrahydrocannabinol and CP 55, 940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys
42. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man
43. Mechanisms of abuse
44. Behavioral and biochemical interrelations in alcoholism
45. Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine
46. Risperidone pre-treatment reduces the euphoric effects of experimentally administered cocaine
47. The acute effects of methamphetamine, amphetamine and p-chloroamphetamine on the cortical serotonergic system of the rat brain: Evidence for differences in the effects of methamphetamine and amphetamine
48. Failure of ritanserin to block the discriminative or reinforcing stimulus effects of cocaine
49. Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers
50. Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers
51. Relationship between self-administration of amphetamine and monoamine receptors in brain: Comparison with cocaine
52. Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166)
53. Serotonergic modulation of the discriminative-stimulus effects of cocaine in squirrel monkeys
54. Roler of the serotonin uptake carrier in the neurochemical response to methamphetamine: Effects of citalopram and chlorimipramine
55. Amphetamine: Effects on catecholamine systems and behavior
56. A self-administered short Michigan Alcoholism Screening Test (SMAST)
57. Chronopharmacokinetics and chronopharmacodynamics of dextromethamphetamine in man
58. Cocaine blocking effects of ondansetron
59. Psychoactivity of ritanserin and its interaction with intravenous cocaine
60. Systemic and local cocaine increase extracellular serotonin in the nucleus accumbens
61. Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence
62. Behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice
63. Pharmacokinetics of neuroleptics
64. Relationship between subjective effects of cocaine and dopamine transporter occupancy
65. Fluoxetine alters the effects of intravenous cocaine in humans
66. Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine
67. Mazindol self-administration in the rhesus monkey
68. A psychomotor stimulant theory of addiction